Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.

Palm AA, Lemey P, Jansson M, Månsson F, Kvist A, Szojka Z, Biague A, da Silva ZJ, Rowland-Jones SL, Norrgren H, Esbjörnsson J, Medstrand P.

MBio. 2019 Jan 8;10(1). pii: e01245-18. doi: 10.1128/mBio.01245-18.

2.

HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya.

Hassan AS, Esbjörnsson J, Wahome E, Thiong'o A, Makau GN, Price MA, Sanders EJ.

PLoS One. 2018 Dec 18;13(12):e0206177. doi: 10.1371/journal.pone.0206177. eCollection 2018.

3.

Evolutionary analysis of the Chikungunya virus epidemic in Mexico reveals intra-host mutational hotspots in the E1 protein.

Muñoz-Medina JE, Garcia-Knight MA, Sanchez-Flores A, Monroy-Muñoz IE, Grande R, Esbjörnsson J, Santacruz-Tinoco CE, González-Bonilla CR.

PLoS One. 2018 Dec 14;13(12):e0209292. doi: 10.1371/journal.pone.0209292. eCollection 2018.

4.

Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study.

Esbjörnsson J, Månsson F, Kvist A, da Silva ZJ, Andersson S, Fenyö EM, Isberg PE, Biague AJ, Lindman J, Palm AA, Rowland-Jones SL, Jansson M, Medstrand P, Norrgren H; Sweden and Guinea-Bissau Cohort Research Group.

Lancet HIV. 2018 Nov 1. pii: S2352-3018(18)30254-6. doi: 10.1016/S2352-3018(18)30254-6. [Epub ahead of print]

PMID:
30392769
5.

Prevalence of HIV-1 pretreatment drug resistance among treatment naïve pregnant women in Bissau, Guinea Bissau.

Wilhelmson S, Månsson F, Lopatko Lindman J, Biai A, Esbjörnsson J, Norrgren H, Jansson M, Medstrand P; SWEGUB CORE group.

PLoS One. 2018 Oct 31;13(10):e0206406. doi: 10.1371/journal.pone.0206406. eCollection 2018.

6.

Low-Bias RNA Sequencing of the HIV-2 Genome from Blood Plasma.

James KL, de Silva TI, Brown K, Whittle H, Taylor S, McVean G, Esbjörnsson J, Rowland-Jones SL.

J Virol. 2018 Dec 10;93(1). pii: e00677-18. doi: 10.1128/JVI.00677-18. Print 2019 Jan 1.

7.

Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak.

Andrews SM, Zhang Y, Dong T, Rowland-Jones SL, Gupta S, Esbjörnsson J.

Sci Rep. 2018 Apr 10;8(1):5743. doi: 10.1038/s41598-018-23913-2.

8.

Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden.

Andersson E, Nordquist A, Esbjörnsson J, Flamholc L, Gisslén M, Hejdeman B, Marrone G, Norrgren H, Svedhem V, Wendahl S, Albert J, Sönnerborg A.

AIDS. 2018 Apr 24;32(7):877-884. doi: 10.1097/QAD.0000000000001763.

PMID:
29369826
9.

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis.

Hassan AS, Hare J, Kamini G, Yindom LM, Kamali A, Karita E, Kilemba W, Price MA, Borrow P, Bjorkman P, Albert J, Kaleebu P, Allan S, Fast P, Hunter E, Gilmour J, Ndung'u T, Rowland-Jones S, Sanders EJ, Esbjornsson J.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.034. doi: 10.1093/ve/vew036.034. eCollection 2017 Mar. No abstract available.

10.

Genetic characterization of human immunodeficiency virus type 1 transmission in the Middle East and North Africa.

Sallam M, Şahin GÖ, Ingman M, Widell A, Esbjörnsson J, Medstrand P.

Heliyon. 2017 Jul 10;3(7):e00352. doi: 10.1016/j.heliyon.2017.e00352. eCollection 2017 Jul.

11.

Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996-2012.

Sallam M, Şahin GÖ, Indriðason H, Esbjörnsson J, Löve A, Widell A, Gottfreðsson M, Medstrand P.

Infect Ecol Epidemiol. 2017 Jun 13;7(1):1328964. doi: 10.1080/20008686.2017.1328964. eCollection 2017.

12.

Defining HIV-1 transmission clusters based on sequence data.

Hassan AS, Pybus OG, Sanders EJ, Albert J, Esbjörnsson J.

AIDS. 2017 Jun 1;31(9):1211-1222. doi: 10.1097/QAD.0000000000001470. Review.

13.

Molecular epidemiology of HIV-1 in Iceland: Early introductions, transmission dynamics and recent outbreaks among injection drug users.

Sallam M, Esbjörnsson J, Baldvinsdóttir G, Indriðason H, Björnsdóttir TB, Widell A, Gottfreðsson M, Löve A, Medstrand P.

Infect Genet Evol. 2017 Apr;49:157-163. doi: 10.1016/j.meegid.2017.01.004. Epub 2017 Jan 7.

PMID:
28082188
14.

HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries.

Esbjörnsson J, Mild M, Audelin A, Fonager J, Skar H, Bruun Jørgensen L, Liitsola K, Björkman P, Bratt G, Gisslén M, Sönnerborg A, Nielsen C; SPREAD/ESAR Programme, Medstrand P, Albert J.

Virus Evol. 2016 Apr 27;2(1):vew010. eCollection 2016 Jan.

15.

Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection.

Garcia-Knight MA, Slyker J, Payne BL, Pond SL, de Silva TI, Chohan B, Khasimwa B, Mbori-Ngacha D, John-Stewart G, Rowland-Jones SL, Esbjörnsson J.

Sci Rep. 2016 Jul 12;6:29536. doi: 10.1038/srep29536.

16.

Molecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns.

Ederth J, Jern C, Norder H, Magnius L, Alm E, Rognsvåg BK, Sundin CG, Brytting M, Esbjörnsson J, Mild M.

Infect Ecol Epidemiol. 2016 Feb 5;6:30670. doi: 10.3402/iee.v6.30670. eCollection 2016.

17.

Differential effects of sex in a West African cohort of HIV-1, HIV-2 and HIV-1/2 dually infected patients: men are worse off.

Jespersen S, Hønge BL, Esbjörnsson J, Medina C, da Silva Té D, Correira FG, Laursen AL, Østergaard L, Andersen A, Aaby P, Erikstrup C, Wejse C; Bissau HIV Cohort study group.

Trop Med Int Health. 2016 Feb;21(2):253-62. doi: 10.1111/tmi.12646. Epub 2015 Dec 21.

18.

Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency.

Karlsson U, Repits J, Antonsson L, Cederfjäll E, Ljungberg B, Ålenius M, Sabirsh A, Gisslen M, Esbjörnsson J, Jansson M.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):e79-82. doi: 10.1097/QAI.0000000000000873. No abstract available.

19.

Cocirculation of several similar but unique HIV-1 recombinant forms in Guinea-Bissau revealed by near full-length genomic sequencing.

Palm AA, Esbjörnsson J, Månsson F, Biague A, da Silva ZJ, Norrgren H, Jansson M, Medstrand P.

AIDS Res Hum Retroviruses. 2015 Sep;31(9):938-45. doi: 10.1089/AID.2015.0073. Epub 2015 Jul 16.

PMID:
26066756
20.

Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

AIDS. 2014 Apr 24;28(7):949-57.

PMID:
24812673
21.

Effect of HIV-2 infection on HIV-1 disease progression and mortality.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

AIDS. 2014 Feb 20;28(4):614-5. doi: 10.1097/QAD.0000000000000142. No abstract available.

PMID:
24469002
22.

The origin and emergence of an HIV-1 epidemic: from introduction to endemicity.

Bruhn CA, Audelin AM, Helleberg M, Bjorn-Mortensen K, Obel N, Gerstoft J, Nielsen C, Melbye M, Medstrand P, Gilbert MT, Esbjörnsson J.

AIDS. 2014 Apr 24;28(7):1031-40. doi: 10.1097/QAD.0000000000000198.

PMID:
24451158
23.

Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3.

Palm AA, Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Biague A, da Silva ZJ, Jansson M, Norrgren H, Medstrand P.

J Infect Dis. 2014 Mar 1;209(5):721-8. doi: 10.1093/infdis/jit416. Epub 2013 Aug 9.

PMID:
23935204
24.

Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness.

Nowroozalizadeh S, Gudmundsdotter L, Hejdeman B, Andersson L, Esbjörnsson J, Medstrand P, Sandström E, Gaines H, Wahren B, Jansson M.

Hum Vaccin Immunother. 2013 Oct;9(10):2103-10. doi: 10.4161/hv.25154. Epub 2013 Jun 4.

25.

High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.

Mild M, Gray RR, Kvist A, Lemey P, Goodenow MM, Fenyö EM, Albert J, Salemi M, Esbjörnsson J, Medstrand P.

Infect Genet Evol. 2013 Oct;19:369-77. doi: 10.1016/j.meegid.2013.05.004. Epub 2013 May 11.

PMID:
23672855
26.

Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

N Engl J Med. 2012 Jul 19;367(3):224-32. doi: 10.1056/NEJMoa1113244.

27.

Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.

Karlsson U, Antonsson L, Ljungberg B, Medstrand P, Esbjörnsson J, Jansson M, Gisslen M.

AIDS. 2012 Sep 10;26(14):1739-44. doi: 10.1097/QAD.0b013e3283560791.

PMID:
22695299
28.

Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.

Ozkaya Sahin G, Holmgren B, da Silva Z, Nielsen J, Nowroozalizadeh S, Esbjörnsson J, Månsson F, Andersson S, Norrgren H, Aaby P, Jansson M, Fenyö EM.

J Virol. 2012 Jan;86(2):961-71. doi: 10.1128/JVI.06315-11. Epub 2011 Nov 9.

29.

Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.

Fenyö EM, Esbjörnsson J, Medstrand P, Jansson M.

J Intern Med. 2011 Dec;270(6):520-31. doi: 10.1111/j.1365-2796.2011.02455.x. Epub 2011 Oct 27.

30.

Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.

Vinner L, Holmgren B, Jensen KJ, Esbjornsson J, Borggren M, Hentze JL, Karlsson I, Andresen BS, Gram GJ, Kloverpris H, Aaby P, Da Silva ZJ, Fenyö EM, Fomsgaard A.

APMIS. 2011 Aug;119(8):487-97. doi: 10.1111/j.1600-0463.2011.02763.x. Epub 2011 May 14.

PMID:
21749448
31.

HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations.

Esbjörnsson J, Mild M, Månsson F, Norrgren H, Medstrand P.

PLoS One. 2011 Feb 18;6(2):e17025. doi: 10.1371/journal.pone.0017025.

32.

Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.

Esbjörnsson J, Månsson F, Martínez-Arias W, Vincic E, Biague AJ, da Silva ZJ, Fenyö EM, Norrgren H, Medstrand P.

Retrovirology. 2010 Mar 22;7:23. doi: 10.1186/1742-4690-7-23.

33.

Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.

Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.

PMID:
19446658
34.

Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.

Mild M, Esbjörnsson J, Fenyö EM, Medstrand P.

J Virol. 2007 Apr;81(7):3369-76. Epub 2007 Jan 24.

35.

Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.

Repits J, Oberg M, Esbjörnsson J, Medstrand P, Karlsson A, Albert J, Fenyö EM, Jansson M.

J Gen Virol. 2005 Oct;86(Pt 10):2859-69.

PMID:
16186242

Supplemental Content

Loading ...
Support Center